“Antitumor and Antimetastatic Activity of a Novel Pyrimidin-4-One Derivative in the B16–F10 Melanoma Mouse Model: A Pilot Study”. Voprosy Onkologii, vol. 72, no. 4, Sept. 2026, p. 2630, https://doi.org/10.37469/0507-3758-2026-72-4-2630.